https://www.selleckchem.com/pr....oducts/3-methyladeni
infants of non-encephalopathy during ET. Allogeneic hematopoietic cell transplantation (HCT) outcomes may be predicted by published risk scores; however, the ideal system has not been identified for acute leukemias. We retrospectively examined the Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI), modified European Group for Blood and Marrow Transplantation (mEBMT), EBMT-Alternating Decision Tree (ADT), and others on 231 patients with acute leukemia. Acute myeloid leukemia was diagnosed in 200 patients, and acute lym
Curtir
Comentario
Compartilhar
